Navigation Links
New Study Shows Masimo's Noninvasive Pleth Variability Index Provides Similar Ability to Assess Fluid Responsiveness During Surgery as More Costly and Invasive Method
Date:4/19/2012

g, March 25, 2009, Brussels, Belgium. Available online here.
[3] Zimmerman M., Feibicke T., Keyl C., Prasser C., Moritz S., Graf B., and Wiesenack C. "Accuracy of Stroke Volume Variation Compared with Pleth Variability Index to Predict Fluid Responsiveness in Mechanically-ventilated Patients Undergoing Major Surgery."  European Journal of Anaesthesiology June 2010; 27(6):555-61. Available online here.
[4] Forget P., Cannesson M. "Fluid Responsiveness Monitoring in Surgically and Critically Ill Patients: Clinical Impact of Goal-Directed Therapy." AKH Inc. and Applied Clinical Education. September 2010; SR1047. Available online here.

About Masimo
Masimo (NASDAQ: MASI) is the global leader in innovative noninvasive monitoring technologies that significantly improve patient care—helping solve "unsolvable" problems. In 1995, the company debuted Measure-Through Motion and Low Perfusion pulse oximetry, known as Masimo SET®, which virtually eliminated false alarms and increased pulse oximetry's ability to detect life-threatening events. More than 100 independent and objective studies demonstrate Masimo SET provides the most reliable SpO2 and pulse rate measurements even under the most challenging clinical conditions, including patient motion and low peripheral perfusion. In 2005, Masimo introduced rainbow SET® Pulse CO-Oximetry™ technology, allowing noninvasive and continuous monitoring of blood constituents that previously required invasive procedures, including total hemoglobin (SpHb®), oxygen content (SpOC™), carboxyhemoglobin (SpCO®), methemoglobin (SpMet®), and Pleth Variability Index (PVI®), in addition to SpO2, pulse r
'/>"/>

SOURCE Masimo Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Phase 2b Study of Boehringer Ingelheims Interferon-Free Hepatitis C Treatment Shows Undetectable Virus in HCV Genotype-1 Patients 12 Weeks After Treatment Ended (SVR12)
2. CrystalGenomics Announces Positive Results from Phase 2b Osteoarthritis Study of CG100649
3. Morphotek®, Inc. Announces Initiation of MORAb-004 Phase 2 Study in Metastatic Colorectal Cancer
4. Biodel Reports Positive Top-Line Results from Study of Experimental Ultra-Rapid-Acting Insulin Formulations
5. Encouraging Phase III Study Results Show PET Imaging with Florbetaben Reliably Detects Beta-Amyloid in the Brain
6. Legacy® and Lung Cancer Alliance Hail the Release of New Study Showing Lung Cancer Screening is Cost Effective
7. Bioness Initiates Study of Neuromodulation System for Chronic Peripheral Nerve Pain
8. Study Confirms Soy Isoflavones Reduce Menopausal Hot Flashes
9. Bionovos Independent Data Safety Monitoring Board Recommends Continuation of Phase 3 Study for Menerba™
10. 12 Month TRAM Data Collated Using TIGR® Matrix Surgical Mesh in a Randomized Controlled Study Presented at MAPACS 2012
11. Patients Who Know Their Gene Test Results are More Likely to Regularly Take and Remain on Statins, Study at ACC Shows
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)...  ANI Pharmaceuticals, Inc. (NASDAQ: ANIP ) ... second quarter and year-to-date 2014 financial results on Monday, ... financial markets. The earnings press release will be accessible ... www.anipharmaceuticals.com . Arthur S. Przybyl ... C. Arnold , Vice President and Chief Financial Officer, ...
(Date:7/28/2014)... CLARA, Calif. , July 28, 2014  ProteinSimple ... assay for the Simple Western. This new assay allows users ... For the first time, Simple Western users can analyze ... The Simple Western has changed protein analysis as ... hassles of Western blot protocols - no messy gels, ...
(Date:7/28/2014)... 2014 OmPrompt today announces ... help it meet the global demand for customer ... logistics. Albion joins Shackleton Ventures.      ... the past 18 months OmPrompt has underpinned accelerated ... team and its operations. The new funding will ...
Breaking Medicine Technology:ANI Pharmaceuticals Schedules Conference Call for Second Quarter 2014 Financial Results 2ProteinSimple Says "Never Run a Gel Again!" 2OmPrompt Funded for Customer Automation Management Market Expansion 2
... 30 Transgenomic, Inc. (OTC,Bulletin Board: TBIO), a ... National Cancer Institute had approved a proposal to,perform ... in,the NCI 60 cancer cell line panel., ... warning,signal in several different types of cancer. This ...
... Spherix Incorporated,(Nasdaq: SPEX ) announced today that it ... manufacturer of bulk pharmaceutical ingredients,to supply a portion of ... of the unique sugar as a treatment for Type ... Practice) production batches,of D- tagatose for the Spherix New ...
Cached Medicine Technology:Transgenomic Establishes Collaboration With the National Cancer Institute to Investigate Mitochondrial Genome and Associated Nuclear Genes in Cancer Cell Lines 2Transgenomic Establishes Collaboration With the National Cancer Institute to Investigate Mitochondrial Genome and Associated Nuclear Genes in Cancer Cell Lines 3Spherix D-tagatose to be Supplied by Inalco SpA 2
(Date:7/28/2014)... According to court documents, the conflict dates to November ... Group (TMG), met with Rafael H. Harel, principal owner ... a broad project outline, were agreed upon for the development ... and marketing. , Though Caller continued to express ... of the project, praise was not accompanied by payment. The ...
(Date:7/28/2014)... 2014 TherapySites, the leading ... announced today its affiliation with the Illinois Association ... relationship allows TherapySites to continue to extend their online ... promotional offers. , “There has been a fundamental shift ... With nearly 3 billion Internet users, it is so ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 According to the ... is a comprehensive guide that will help people get rid ... readers all the necessary information about heartburn and acid reflux. ... truth about heartburn , and risk factors for reflux disease. ... will help people get rid of symptoms of reflux disease ...
(Date:7/28/2014)... New York, NY (PRWEB) July 28, 2014 ... completed the exit of its investment in Loftware, Inc., ... Partners of Boston. Shore Points was the lead investor ... which the Company has become the leading international provider ... applications. , “Loftware has been a great investment for ...
(Date:7/27/2014)... 28, 2014 Hyaluronic Acid can hold ... the key to the power of Hyaluronic Serums. , ... Heshelow, founder of Sublime Beauty®. "But like collagen, it ... as ours improves skin moisture-retention and radiance." , ... to a healthy and beautiful look. Key Ingredients in ...
Breaking Medicine News(10 mins):Health News:Calko Medical Center Loses Website Twice over Non-Payment, According to Court Documents 2Health News:TherapySites (Websites for Therapists) Partners with the Illinois Association for Marriage and Family Therapy 2Health News:Heartburn No More Pdf Review Exposes Jeff Martin's Guide For Treating Heartburn – Vkool.com 2Health News:Heartburn No More Pdf Review Exposes Jeff Martin's Guide For Treating Heartburn – Vkool.com 3Health News:Shore Points Capital Announces Sale of Portfolio Company Loftware 2Health News:Aging or Dry Skin Benefits from Hyaluronic Serum; Now 30% Off Sale at Sublime Beauty® 2
... Parental Loss Support Group helps adults cope with feelings of grief after ... 2nd, 10:00-11:30am, at Hospice By The Bay, 17 East Sir Francis Drake ... ... Hospice By The Bay,s eight-week Parental Loss Support Group helps adults ...
... Inc., a leading online retailer of contact lenses in the United States ... dry winter eyes can be easily prevented. , ... Bellevue, WA (PRWEB) ... retailer of contact lenses in the United States wants to ...
... marijuana use may significantly increase a man,s risk of ... to a study by researchers at Fred Hutchinson Cancer ... 9 in the journal Cancer ., The researchers ... of diagnosis was associated with a 70 percent increased ...
... less likely to survive the disease than white women, and ... decades to narrow this racial difference. That is the conclusion ... issue of CANCER , a peer-reviewed journal of the ... black women are more likely to die from uterine cancers ...
... 2009 Introduced by Congressman LewisWASHINGTON, Feb. 8 ... to help blind persons receiving Social Security Disability ... Blind Persons Return to Work Act of 2009 ... persons from reentering the workforce and will facilitate ...
... in the blood that influences immune cell migration also ... the build-up and breakdown of bones in the body. ... may provide a new target for scientists developing therapies ... rheumatoid arthritis. , The study comes from ...
Cached Medicine News:Health News:Hospice By The Bay Grief Group Helps Adults Who've Lost a Parent 2Health News:Contact Lens Wearers Should Blink More Often During Winter - Tips from VisionDirect.com to Keep Eyes Moist During Dry Winter Months 2Health News:Contact Lens Wearers Should Blink More Often During Winter - Tips from VisionDirect.com to Keep Eyes Moist During Dry Winter Months 3Health News:Marijuana use linked to increased risk of testicular cancer 2Health News:Marijuana use linked to increased risk of testicular cancer 3Health News:Marijuana use linked to increased risk of testicular cancer 4Health News:Black women with uterine cancers more likely to die than white patients 2Health News:National Federation of the Blind Praises Bill to Create Work Incentives and Opportunity 2Health News:Scientists discover key factor in controlling the breakdown of bone 2Health News:Scientists discover key factor in controlling the breakdown of bone 3
... Alsius heat exchange catheters connect to the ... and maintains a target temperature input by ... patient core temperature and automatically adjusts the ... catheter (0-42C), providing consistent maintenance of temperature. ...
... vascular access. Hollow stylet design ... puncture with two-part needle. Initial ... while maintaining thumb position on ... hub of the stylet. Supplied ...
Used to introduce balloon, diagnostic and guiding catheters, or other devices for intervention....
Used for percutaneous introduction of balloon, electrode and closed or non-tapered end catheters for vascular and non-vascular use....
Medicine Products: